Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
http://www.youtube.com/watch?v=yXMddEIdusg[EXTRACT]
Dr. Samuel Aguiar Jr. - Hospital do Câncer - AC CamargoMédico do Departamento de Cirurgia Pélvicahttp://199.238.143.96/index.php?option=com_content&task=view&id=29&Itemid=33
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer.
The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
http://barley-benefits.com ORDER NOW! Call or Text: Philippines: 0916-3868503 (Globe) / 0947-2298138 (Smart) U.A.E: +971-507124671; Qatar: +974-55247071; eMail: barleypure.nz@gmail.com FREE DELIVERY WITHIN METRO MANILA! Be A Member of Sante Pure Barley for ONLY P3,988.00 and Get HUGE DISCOUNTS of up to 50% - REGISTER NOW! - http://barley-benefits.com http://santepurebarley.multiply.com/ http://www.facebook.com/PureBarley http://bit.ly/pfYQf0 http://bit.ly/y934jP http://bit.ly/A1nFuv http://bit.ly/zIkVuf http://bit.ly/A3cKrS http://bit.ly/waX9di http://bit.ly/zJRkVi
http://barley-benefits.com -- Another amazing testimonial by a cervical cancer survivor cured by Sante Pure Barley. To Order or Inquire: Call or Text: Philippines: 0916-3868503 (Globe) / 0947-2298138 (Smart); U.A.E: +971-507124671; Qatar: +974-55247071; http://santepurebarley.multiply.com/ http://www.facebook.com/PureBarley http://bit.ly/pfYQf0 http://bit.ly/y934jP http://bit.ly/A1nFuv http://bit.ly/zIkVuf http://bit.ly/A3cKrS http://bit.ly/waX9di http://bit.ly/zJRkVi
On November 17, millions of Americans will mark the American Cancer Society’s 36th annual Great American Smokeout by giving up smoking for the day, and maybe for good. Because smoking can trigger asthma symptoms in children, quitting is an important first step toward protecting kids’ health. BeSmartBeWell.com tells parents the steps they can take on the Great American Smokeout, and every day of the year, to lower the risk for childhood asthma.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childhoodasthma/50826/
Avon Products, Inc. celebrated the culmination of its 125th anniversary year last night at the Avon Foundation for Women Global Voices for Change Gala by honoring global champions working to end breast cancer and domestic violence, and by announcing the winners of Avon’s first-ever global online singing talent search for women and songwriting competition for women and men, Avon Voices. Avon Chairman and CEO Andrea Jung, Fergie, Natasha Bedingfield, Delta Goodrem, Ashley Greene and more than 800 guests and performers from 39 countries attended this star-studded celebration at the Marriot Marquis in New York City’s Times Square, which raised more than $2.3 million for the Avon Foundation for Women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46211-avon-global-voices-for-change-gala
It's no surprise that about 1 in 8 women in the United States will develop invasive breast cancer over the course of her lifetime. In fact, for women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer. In honor of Breast Cancer Awareness Month in October, our national healthcare expert is here to discuss educating and empowering women to take charge of their own breast health.
Today in New York, Avon Foundation for Women Honorary Chairperson Reese Witherspoon recognized Breast Cancer Awareness Month at the 2011 Global Breast Cancer Congress – where she launched a new Avon Foundation for Women-funded global breast cancer scholarship program – and at the Avon Walk for Breast Cancer – where she presented more than $9.1 million in grants to New York-area breast cancer programs.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46209-reese-witherspoon-announces-avon-global-breast-cancer-scholars-program
With the kick-off of pro football season and September marking National Prostate Cancer Awareness Month, the American Urological Association (AUA) Foundation and the National Football League (NFL) have teamed up for a third year to educate men about prostate health and encourage them to join the “Know Your Stats” campaign. With the support of an increasing number of NFL greats and prostate cancer survivors, the national campaign is focused on turning awareness into action by encouraging men to know their risks and get tested.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51874-aua-foundation-nfl-mike-haynes-know-your-stats-prostate-cancer-awareness
